|
Mesoridazine Besylate
(mes'' oh rid' a zeen bes' i late).
10H-Phenothiazine, 10-[2-(1-methyl-2-piperidinyl)ethyl]-2-(methylsulfinyl)-, (±)-, monobenzenesulfonate. (±)-10-[2-(1-Methyl-2-piperidyl)ethyl]-2-(methylsulfinyl)phenothiazine monobenzenesulfonate » Mesoridazine Besylate contains not less than 98.0 percent and not more than 102.0 percent of C21H26N2OS2·C6H6O3S, calculated on the dried basis.
Packaging and storage
Preserve in tight, light-resistant containers.
USP Reference standards
[noteThroughout the following procedures, protect test or assay specimens, the USP Reference Standard, and solutions containing them, by conducting the procedures without delay, under subdued light, or using low-actinic glassware. ]
Identification
B:
Ultraviolet Absorption
Solution:
10 µg per mL.
Medium:
methanol.
Absorptivities at 263 nm, calculated on the dried basis, do not differ by more than 3.0%.
pH
Loss on drying
Residue on ignition
Heavy metals, Method II
Selenium
Ordinary impurities
Test solution:
a solution in methanol having a known concentration of 14.1 mg per mL equivalent to 10 mg of mesoridazine per mL.
Standard solution:
methanol.
Eluant:
a mixture of chloroform, isopropyl alcohol, and ammonium hydroxide (87:12:1).
Visualization:
3, followed by spraying with 3% (v/v) aqueous hydrogen peroxide.
Application volume:
10 µL.
Limit:
3.0%.
Assay
Dissolve about 150 mg of Mesoridazine Besylate, accurately weighed, in 70 mL of acetic anhydride, and titrate with 0.1 N perchloric acid VS, determining the endpoint potentiometrically. Perform a blank determination, and make any necessary correction. Each mL of 0.1 N perchloric acid is equivalent to 27.24 mg of C21H26N2OS2·C6H6O3S.
Auxiliary Information
Please check for your question in the FAQs before contacting USP.
USP35NF30 Page 3822
Pharmacopeial Forum: Volume No. 30(4) Page 1262
|